Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - STOCK-BASED COMPENSATION
Stock-based Compensation CRVS - Corvus Pharmaceuticals, Inc.
2.15 M
LAST VALUE
-28.77%
2 YEAR CAGR
-21.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR